The Royal Society of Medicine is presenting a one-day conference in association with the charity Cardiac Risk in the Young, about the latest developments in our understanding of the causes and prevention of young sudden cardiac death, and how to ensure the best quality of life for those living with diagnosed cardiac conditions.
In the medical community around the world, CRY is best known for research. Our research has helped transform our understanding of young sudden cardiac death, the conditions that cause it, and how we can save more young lives. Our Research Fellows have been instrumental in our developments over the years, so we spoke with former CRY
By Alison Cox, from issue 82 of the CRY Update magazine. I finally confirmed that Sanjay was not your average person when he told me – during a discussion we were having on reminiscing – that he started writing his thoughts and experiences down when he was four. He was a serious, curious child and wanted
How CRY’s research impacted the investigation/management of people at risk of sudden cardiac death CRY’s latest webinar held on the 17th December 2020 with CRY’s Consultant Cardiologist Dr Michael Papadakis – Dr Papadakis gave a presentation on how CRY’s research has impacted the investigation and management of people with conditions that can cause sudden cardiac death.
Dr Michael Papadakis has been a key member of the CRY team for years after first joining the charity when he started his training as a CRY Research Fellow in 2007. He’s continued to develop education in the sports cardiology field by building educational material for the European Society of Cardiology (ESC) and launched a novel
Former CRY Research Fellow Dr Chris Miles’ recent research helped demonstrate how new computer software can help identify and analyse abnormalities in the heart that we may not be able to see otherwise. Dr Miles’ paper, entitled “Morphometric characterization of collagen and fat in normal ventricular myocardium” (Miles C, Westaby J, Ster I C, et al.
Former CRY Research Fellow Dr Gherado Finocchiaro completed a study into hypertrophic cardiomyopathy (HCM), aiming to determine the incidence of HCM in first-degree relatives of decedents from sudden death with idiopathic left ventricular hypertrophy. The paper, entitled “Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy” (Finocchiaro G et al.
Former CRY Research Fellow Dr Lynne Millar recently completed a study into dilated cardiomyopathy in athletes, entitled “Differentiation between athlete’s heart and dilated cardiomyopathy in athletic individuals” (Millar L, Fanton Z, Finocchiaro G, et al. Heart, July 2020). This paper intended to distinguish the difference between dilated cardiomyopathy and typical, healthy changes that can occur in
CRY’s research programme has had a huge impact on our understanding of the causes and prevention of young sudden cardiac death as well as the way we treat those at risk.
CRY Consultant Cardiologist Professor Sanjay Sharma speaking at the 2018 CRY International Medical Conference. The CRY International Medical Conference is our most important research event every year. It provides an opportunity for leading experts in sports cardiology, inherited cardiac diseases and young sudden cardiac death to share their new research, and discuss the diagnosis and management
Preventing young sudden cardiac deaths through awareness, screening and research, and supporting affected families.
Head Office:
Unit 1140B, The Axis Centre,
Cleeve Road, Leatherhead,
Surrey KT22 7RD
Tel: 01737 363222
Privacy Policy
Safeguarding Policy
Accessibility Statement
Email: [email protected]
Registered Charity in England & Wales (1050845) & in Scotland (SC052581)
